PATENT CLAIM ANALYSIS

Application Number: 16129412
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["424", "450000"]

Abstract:
The present invention provides, among other things, methods and compositions for delivering an antibody in vivo by administering to a subject in need thereof one or more mRNAs encoding a heavy chain and a light chain of an antibody, and wherein the antibody is expressed systemically in the subject. In some embodiments, the one or more mRNAs comprise a first mRNA encoding the heavy chain and a second mRNA encoding the light chain of the antibody.

Claim (Index 2):
The method of  claim 1 , wherein the one or more mRNAs comprise a first mRNA polynucleotide encoding the heavy chain and a second mRNA polynucleotide encoding the light chain of the antibody.

Metadata:
- Claim Count in Document: 48.0
- Percentile: 97.0
- Lexical Diversity: 1.78261
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14775835', '14959453', '15482431', '15995889', '15996146']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7279463128337244
- 35 USC 102 Novelty (BERT): 0.584490690899945
- Combined Prediction Score: 0.7136007506403464
- Mean Citation Score: 314.316848
- Max Citation Score: 503.29144
- Similarity Product: 387.68487171409606

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test